The survival of Listeria monocytogenes during long term desiccation is facilitated by sodium chloride and organic material.

B. F. Vogel,L. Hansen,H. Mordhorst,L. Gram

DOI: https://doi.org/10.1016/j.ijfoodmicro.2010.03.035

2010-06-15

Abstract:

What problem does this paper attempt to address?

Suppression of adrenocortical function in the rat by the prolonged administration of adrenal steroids. Proc. Soc. Endocr. 67th.

P. D’arcy,E. M. Howard

Journal of Endocrinology

Abstract:
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.

T. Whiteside

DOI: https://doi.org/10.1016/J.SEMCANCER.2005.07.008

IF: 17.012

2006-02-01

Seminars in Cancer Biology

Abstract:
Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.

J. Nitiss,P. Vilalta,H. Wu,J. McMahon

1994-10-01

Molecular Pharmacology

Abstract:Anti-topoisomerase II agents represent a major class of anticancer therapeutic agents. Resistance to this class of agents can be mediated by several possible mechanisms. One mechanism may involve mutations in the structural gene(s) for topoisomerases, altering the drug sensitivity of the enzymes. Several mutations have been described in mammalian cell lines that were selected for resistance to topoisomerase II-targeting drugs such as Adriamycin, etoposide, or amsacrine. The difficulty of performing genetic analysis in mammalian cell lines has complicated the determination of whether the observed mutations are responsible for drug resistance. We have reconstructed, in the yeast topoisomerase II gene, the arginine to glutamine mutation at position 450 of human topoisomerase II alpha that was originally identified by Bugg et al. [Proc. Natl. Acad. Sci. USA 88:7654-7658 (1991)]. Mutation of Lys439, the equivalent amino acid in the yeast protein, to either glutamine or glutamic acid confers resistance to etoposide and amsacrine. Interestingly, in diploid yeast cells the heterozygous mutation can still confer partial drug resistance, compared with a diploid strain that is homozygous for wild-type topoisomerase II. Because mutations in the topoisomerase II gene that can confer dominant resistance to anti-topoisomerase II agents are relatively rare, mutations in the gyrB region may be important in the development of clinical drug resistance.
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR

Lianhua Dong,Junbo Zhou,Chunyan Niu,Quanyi Wang,Yang Pan,Sitong Sheng,Xia Wang,Yongzhuo Zhang,Jiayi Yang,Manqing Liu,Yang Zhao,Xiaoying Zhang,Tao Zhu,Tao Peng,Jie Xie,Yunhua Gao,Di Wang,Xinhua Dai,Xiang Fang

DOI: https://doi.org/10.1016/j.talanta.2020.121726

IF: 6.1

2021-03-01

Talanta

Abstract:The outbreak of COVID-19 caused by a novel Coronavirus (termed SARS-CoV-2) has spread to over 210 countries around the world. Currently, reverse transcription quantitative qPCR (RT-qPCR) is used as the gold standard for diagnosis of SARS-CoV-2. However, the sensitivity of RT-qPCR assays of pharyngeal swab samples are reported to vary from 30% to 60%. More accurate and sensitive methods are urgently needed to support the quality assurance of the RT-qPCR or as an alternative diagnostic approach. A reverse transcription digital PCR (RT-dPCR) method was established and evaluated. To explore the feasibility of RT-dPCR in diagnostic of SARS-CoV-2, a total of 196 clinical pharyngeal swab samples from 103 suspected patients, 77 close contacts and 16 supposed convalescents were analyzed by RT-qPCR and then measured by the proposed RT-dPCR. For the 103 fever suspected patients, 19 (19/25) negative and 42 (42/49) equivocal tested by RT-qPCR were positive according to RT-dPCR. The sensitivity of SARS-CoV-2 detection was significantly improved from 28.2% by RT-qPCR to 87.4% by RT-dPCR. For 29 close contacts (confirmed by additional sample and clinical follow up), 16 (16/17) equivocal and 1 negative tested by RT-qPCR were positive according to RT-dPCR, which is implying that the RT-qPCR is missing a lot of asymptomatic patients. The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 91%, 100% and 93 %, respectively. RT-dPCR is highly accurate method and suitable for detection of pharyngeal swab samples from COVID-19 suspected patients and patients under isolation and observation who may not be exhibiting clinical symptoms.

chemistry, analytical
Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Yee Ling Lau,Ilyiana binti Ismail,Nur Izati binti Mustapa,Meng Yee Lai,Tuan Suhaila Tuan Soh,Afifah Haji Hassan,Kalaiarasu M. Peariasamy,Yee Leng Lee,Maria Kahar Bador Abdul Kahar,Jennifer Chong,Pik Pin Goh

DOI: https://doi.org/10.1371/journal.pone.0245164

IF: 3.7

2021-01-06

PLoS ONE

Abstract:Rapid diagnosis is an important intervention in managing the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) outbreak. Real time reverse transcription polymerase chain reaction (RT-qPCR) remains the primary means for diagnosing the new virus strain but it is time consuming and costly. Recombinase polymerase amplification (RPA) is an isothermal amplification assay that does not require a PCR machine. It is an affordable, rapid, and simple assay. In this study, we developed and optimized a sensitive reverse transcription (RT)-RPA assay for the rapid detection of SARS-CoV-2 using SYBR Green I and/or lateral flow (LF) strip. The analytical sensitivity and specificity of the RT-RPA assay were tested by using 10-fold serial diluted synthetic RNA and genomic RNA of similar viruses, respectively. Clinical sensitivity and specificity of the RT-RPA assay were carried out using 78 positive and 35 negative nasopharyngeal samples. The detection limit of both RPA and RT-qPCR assays was 7.659 and 5 copies/μL RNA, respectively with no cross reactivity with other viruses. The clinical sensitivity and specificity of RT-RPA were 98% and 100%, respectively. Our study showed that RT-RPA represents a viable alternative to RT-qPCR for the detection of SARS-CoV-2, especially in areas with limited infrastructure.

multidisciplinary sciences
Detection of hospital environmental contamination during SARS-CoV-2 Omicron predominance using a highly sensitive air sampling device

Kai Sen Tan,Alicia Xin Yu Ang,Douglas Jie Wen Tay,Jyoti Somani,Alexander Jet Yue Ng,Li Lee Peng,Justin Jang Hann Chu,Paul Anantharajah Tambyah,David Michael Allen

DOI: https://doi.org/10.3389/fpubh.2022.1067575

IF: 5.2

2023-01-10

Frontiers in Public Health

Abstract:Background and objectives The high transmissibility of SARS-CoV-2 has exposed weaknesses in our infection control and detection measures, particularly in healthcare settings. Aerial sampling has evolved from passive impact filters to active sampling using negative pressure to expose culture substrate for virus detection. We evaluated the effectiveness of an active air sampling device as a potential surveillance system in detecting hospital pathogens, for augmenting containment measures to prevent nosocomial transmission, using SARS-CoV-2 as a surrogate. Methods We conducted air sampling in a hospital environment using the AerosolSense TM air sampling device and compared it with surface swabs for their capacity to detect SARS-CoV-2. Results When combined with RT-qPCR detection, we found the device provided consistent SARS-CoV-2 detection, compared to surface sampling, in as little as 2 h of sampling time. The device also showed that it can identify minute quantities of SARS-CoV-2 in designated “clean areas” and through a N95 mask, indicating good surveillance capacity and sensitivity of the device in hospital settings. Conclusion Active air sampling was shown to be a sensitive surveillance system in healthcare settings. Findings from this study can also be applied in an organism agnostic manner for surveillance in the hospital, improving our ability to contain and prevent nosocomial outbreaks.

public, environmental & occupational health
Non-isothermal extension of the Scharfetter-Gummel technique for hot carrier transport in heterostructure simulations

Arlynn W. Smith,A. Rohatgi

DOI: https://doi.org/10.1109/43.256926

1993-10-01

Abstract:Points out that the Scharfetter-Gummel technique is widely used in algorithms for the simulation of isothermal semiconductor devices. Recent interest in the modeling of ultrasmall devices requires a nonisothermal analysis, i.e., a hydrodynamic model. Several nonisothermal extensions to the Scharfetter-Gummel technique for carrier flux have been proposed for homostructure devices. An extension is presented which is suitable for the simulation of both the carrier flux and carrier energy flux equations in heterostructure devices, with the capability of using Fermi-Dirac statistics. Comparison with the extensions of other authors provides verification of the discretization formulation developed here. Limiting cases are discussed with suitable approximations. Calculated values of fluxes are presented for selected nonisothermal and degenerate cases to highlight the need for inclusion of the Fermi-Dirac statistics in the flux formulations. >
Evaluation of diagnostic performance of SARS-CoV-2 infection using digital droplet polymerase chain reaction in individuals with or without COVID-19 symptoms

Yoonjung Kim,Eunyoung Lee,Boyeon Kim,Jinhee Cho,Sook-Won Ryu,Kyung-A Lee

DOI: https://doi.org/10.1016/j.cca.2023.117759

IF: 6.314

2024-01-06

Clinica Chimica Acta

Abstract:Background Reverse transcription-quantitative PCR (RT-qPCR) is commonly used to diagnose SARS-CoV-2, but it has limited sensitivity in detecting the virus in asymptomatic close contacts and convalescent patients. In this study, we propose the use of reverse transcription-digital droplet PCR (RT-ddPCR) to detect SARS-CoV-2 in clinical samples. Methods The clinical performance of RT-ddPCR targeting of ORF1ab and N genes was evaluated in parallel with RT-qPCR using 200 respiratory samples collected from close contacts and patients at different phases of infection. Results The limits of detection (LODs) for RT-ddPCR assays were determined using six dilutions of ACCUPLEX SARS-Cov-2 reference material. The LODs of ORF1ab and N genes were 3.7 copies/reaction and 2.2 copies/reaction, respectively. Compared to RT-qPCR, RT-ddPCR increased the positive rate by 12.0% in 142 samples from SARS-CoV-2-infected patients. Additionally, RT-ddPCR detected SARS-CoV-2 in three of 26 specimens from close contacts that tested negative by RT-qPCR, and infection was confirmed using follow-up samples. Finally, RT-ddPCR improved the equivocal results from RT-qPCR in 56.3% (9/16) of convalescent patient samples. Conclusions Detecting SARS-CoV-2 in samples with low viral loads using RT-qPCR can be challenging. However, our study suggests that RT-ddPCR, with its higher sensitivity and accuracy, is better suited for detecting low viral copies in samples, particularly those from close contacts and convalescent patients.

medical laboratory technology
A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples

Sherif A. El-Kafrawy,Mai M. El-Daly,Ahmed M. Hassan,Reham M. Kaki,Adel M. Abuzenadah,Mohammad A. Kamal,Esam I. Azhar

DOI: https://doi.org/10.3390/healthcare9010037

2021-01-04

Health Care

Abstract:Introduction: the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of acute respiratory disease (COVID-19). SARS-CoV-2 is a positive-strand RNA virus and its genomic characterization has played a vital role in the design of appropriate diagnostics tests. The current RT-PCR protocol for SARS-CoV-2 detects two regions of the viral genome, requiring RNA extraction and several hours. There is a need for fast, simple, and cost-effective detection strategies. Methods: we optimized a protocol for direct RT-PCR detection of SARS-CoV-2 without the need for nucleic acid extraction. Nasopharyngeal samples were diluted to 1:3 using diethyl pyrocarbonate (DEPC)-treated water. The diluted samples were incubated at 95 °C for 5 min in a thermal cycler, followed by a cooling step at 4 °C for 5 min. Samples then underwent reverse transcription real-time RT-PCR in the E and RdRp genes. Results: our direct detection protocol showed 100% concordance with the standard protocol with an average Ct value difference of 4.38 for the E region and 3.85 for the RdRp region. Conclusion: the direct PCR technique was found to be a reliable and sensitive method that can be used to reduce the time and cost of the assay by removing the need for RNA extraction. It enables the use of the assay in research, diagnostics, and screening for COVID-19 in regions with fewer economic resources, where supplies are more limited allowing for wider use for screening.

health care sciences & services,health policy & services
Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications

Yanfang Jiang,Haifeng Wang,Sijia Hao,Yukun Chen,Jiaxue He,Yong Liu,Liguo Chen,Yuanhua Yu,Shucheng Hua

DOI: https://doi.org/10.1016/j.cca.2020.10.032

IF: 6.314

2020-12-01

Clinica Chimica Acta

Abstract:The global coronavirus disease 2019 (COVID-19) pandemic has posed great challenges in people's daily lives. Highly sensitive laboratory techniques played a critical role in clinical COVID-19 diagnosis and management. In this study the feasibility of using a new digital PCR-based detection assay for clinical COVID-19 diagnosis was investigated by comparing its performance with that of RT-PCR. Clinical patient samples and samples obtained from potentially contaminated environments were analyzed. The study included 10 patients with confirmed COVID-19 diagnoses, 32 validated samples of various types derived from different clinical timepoints and sites, and 148 environmentally derived samples. SARS-CoV-2 nucleic acids were more readily detected in respiratory tract samples (35.0%). In analyses of environmentally derived samples, the positivity rate of air samples was higher than that of surface samples, probably due to differences in virus concentrations. Digital PCR detected SARS–CoV–2 in several samples that had previously been deemed negative, including 3 patient-derived samples and 5 environmentally derived samples. In this study digital PCR exhibited higher sensitivity than conventional RT-PCR, suggesting that it may be a useful new method for clinical SARS-CoV-2 detection. Improvement of SARS-CoV-2 detection would substantially reduce the rates of false-negative COVID-19 test results, in particular those pertaining to asymptomatic carriers.

medical laboratory technology
Sampling and detection of corona viruses in air: A mini review

Ali Reza Rahmani,Mostafa Leili,Ghasem Azarian,Ali Poormohammadi

DOI: https://doi.org/10.1016/j.scitotenv.2020.140207

2020-10-01

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a strain of coronaviruses that causes coronavirus disease 2019 (COVID-19). In these days, the spread of the SARS-CoV-2 virus through the air has become a controversial topic among scientists. Various organizations provide standard methods for monitoring biological agents in the air. Nevertheless, there has been no standard recommended method for sampling and determination of viruses in air. This manuscript aimed at reviewing published papers for sampling and detection of corona viruses, especially SARS-Cov-2 as a global health concern. It was found that SARS-Cov 2 was present in some air samples that were collected from patient's rooms in hospitals. This result warrants its airborne transmission potential. However, due to the fact that in the most reviewed studies, sampling was performed in the patient's room, it seems difficult to discriminate whether it is airborne or is transmitted through respiratory droplets. Moreover, some other disrupting factors such as patient distance from the sampler, using protective or oxygen masks by patients, patient activities, coughing and sneezing during sampling time, air movement, air conditioning, sampler type, sampling conditions, storage and transferring conditions, can affect the results. About the sampling methods, most of the used samplers such as PTFE filters, gelatin filers and cyclones showed suitable performance for trapping SARS-Co and MERS-Cov viruses followed by PCR analysis.

environmental sciences
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification

Raphael Nyaruaba,Xiaohong Li,Caroline Mwaliko,Changchang Li,Matilu Mwau,Nelson Odiwour,Elishiba Muturi,Caroline Muema,Junhua Li,Junping Yu,Hongping Wei

DOI: https://doi.org/10.3791/62295

2021-03-31

Abstract:Diagnosis of the ongoing SARS-CoV-2 pandemic is a priority for all countries across the globe. Currently, reverse transcription quantitative PCR (RT-qPCR) is the gold standard for SARS-CoV-2 diagnosis as no permanent solution is available. However effective this technique may be, research has emerged showing its limitations in detection and diagnosis especially when it comes to low abundant targets. In contrast, droplet digital PCR (ddPCR), a recent emerging technology with superior advantages over qPCR, has been shown to overcome the challenges of RT-qPCR in diagnosis of SARS-CoV-2 from low abundant target samples. Prospectively, in this article, the capabilities of RT-ddPCR are further expanded by showing steps on how to develop simplex, duplex, triplex probe mix, and quadruplex assays using a two-color detection system. Using primers and probes targeting specific sites of the SARS-CoV-2 genome (N, ORF1ab, RPP30, and RBD2), the development of these assays is shown to be possible. Additionally, step by step detailed protocols, notes, and suggestions on how to improve the assays workflow and analyze data are provided. Adapting this workflow in future works will ensure that the maximum number of targets can be sensitively detected in a small sample significantly improving on cost and sample throughput.
245 Detection of human respiratory pathogens in air and surface samples collected in several workplaces and public spaces

Peter Raynor,Angie Quiñonez Muñoz,Nader Sobhy,Sagar Goyal,Adepeju Adesina,Susan Arnold,Majid Bagheri Hosseinabadi,Li Li,Puleng Moshele,My Yang,Montserrat Torremorell,Bernard Olson,Muhammad Luqman,Venkatramana Krishna,Sarah Bistodeau,Scott Cunningham

DOI: https://doi.org/10.1093/annweh/wxae035.250

IF: 2.779

2024-06-01

Annals of Work Exposures and Health

Abstract:Abstract Introduction The objective of this research was to develop and demonstrate methods to detect and assess viability of human respiratory viruses and bacteria in air and on surfaces in workplaces and public spaces. Methodology Air and surface samples were collected in a music classroom, medical clinic, dental clinic, basketball arena, and ice hockey arena. Air samples were taken using Non-Viable Andersen Cascade Impactors and either AGI-30 impingers or SKC BioSamplers. Samples from the impactors were eluted using Eagle’s Minimum Essential Medium (MEM) with supplements. MEM was also the collection liquid for the impingement samplers. Surface samples were taken using gauze dipped into MEM. All samples were analyzed on a Luminex MAGPIX System using a NxTAG Respiratory Pathogen Panel (RPP) + SARS-CoV-2. This permitted multiplex detection for 23 viral and bacterial targets per sample. Virus isolation was performed on positive samples to determine if viable virus was present. Results Analyses recovered RNA or DNA from SARS-CoV-2, CoV 229E, CoV OC43, human bocavirus, human metapneumovirus, rhinovirus/enterovirus, and adenovirus. While positive results were found at all sites, more surface samples (47.2%) had positive results than air samples (12.5%). Isolation did not identify viable virus in any of the positive samples. No links were established between virus presence and environmental conditions or general particle concentrations. Conclusions Based on the findings from this initial work, future testing will include greater use of surface sampling and settling substrates, higher flow rate air samplers, and reduced emphasis on size-differentiated sampling.

public, environmental & occupational health
Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care

Dishit P Ghumra,Nishit Shetty,Kevin R McBrearty,Joseph V Puthussery,Benjamin J Sumlin,Woodrow D Gardiner,Brookelyn M Doherty,Jordan P Magrecki,David L Brody,Thomas J Esparza,Jane A O'Halloran,Rachel M Presti,Traci L Bricker,Adrianus C M Boon,Carla M Yuede,John R Cirrito,Rajan K Chakrabarty

DOI: https://doi.org/10.1021/acssensors.3c00512

2023-08-25

Abstract:Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols in patients has been a long-standing technical challenge. Here, we introduce a point-of-care testing platform that directly detects SARS-CoV-2 aerosols in as little as two exhaled breaths of patients and provides results in under 60 s. It integrates a hand-held breath aerosol collector and a llama-derived, SARS-CoV-2 spike-protein specific nanobody bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Laboratory and clinical trial results were within 20% of those obtained using standard testing methods. Importantly, the electrochemical biosensor directly detects the virus itself, as opposed to a surrogate or signature of the virus, and is sensitive to as little as 10 viral particles in a sample. Our platform holds the potential to be adapted for multiplexed detection of different respiratory viruses. It provides a rapid and non-invasive alternative to conventional viral diagnostics.
Efficient Microfluidic-Based Air Sampling/Monitoring Platform for Detection of Aerosol SARS-CoV-2 On-site

Huiwen Xiong,Xin Ye,Yang Li,Jun Qi,Xueen Fang,Jilie Kong

DOI: https://doi.org/10.1021/acs.analchem.0c05154

IF: 7.4

2021-02-26

Analytical Chemistry

Abstract:Airborne pathogens have been considered as highly infectious and transmittable between humans. With the pandemic outbreak of the coronavirus disease 2019 (COVID-19), an on-site diagnostic system-integrated airborne pathogen-monitoring machine is recommended by experts for preventing and controlling the early stage β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread. In this work, a small-volume rotating microfluidic fluorescence chip-integrated aerosol SARS-CoV-2 sampling system was constructed to satisfy the demand for rapid on-site sample collection and detection of SARS-CoV-2. The rotating microfluidic fluorescence system with small volume has very high sensitivity in the detection of SARS-CoV-2 (detection limit of 10 copies/μL with the shortest Ct value of 15 min), which is comparable to reverse transcription polymerase chain reaction (RT-PCR). The precision variation coefficients within/between batches are very low [coefficient of variation (CV) % ≤ 5.0%]. Our work has passed the comprehensive inspection of the microfluidic chip performance by the Shanghai Medical Device Testing Institute [National Medical Inspection (Design) no. 4408] and successfully tested 115 clinical samples. The integrated system exhibits 100% specificity, high sensitivity (10 copies/μL), and good precision (CV % ≤ 5.0%) in the rapid detection of SARS-CoV-2, thus realizing rapid monitoring and diagnostics of SARS-CoV-2 nucleic acid on-site.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c05154?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c05154</a>.Photograph of the microfluidic chip; primer sets targeting ORF1ab and N for SARS-CoV-2 integrated microfluidic assay; ratio optimization between the inner primer and outer primer of ORF1ab and N; optimization of the experimental condition targeting ORF1ab and N; dilutions for SARS-CoV-2 pseudoviral samples targeting ORF1ab and N; detection Results of SARS-CoV-2; detection limit verification of SARS-CoV-2 targeting OFR1ab; different concentrations of SARS-CoV-2 pseudovirus; reproducibility detection results of the ORF1ab target and N gene target; concentrations of various interfering substances; detection results of interfering substances; detection results of the novel coronavirus sample; κ analysis; and analysis of 95% CIs (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05154/suppl_file/ac0c05154_si_001.pdf">PDF</a>).This article has not yet been cited by other publications.

chemistry, analytical
A set operation algorithm for sculptured solids modeled with trimmed patches

M. Casale,J. Bobrow

DOI: https://doi.org/10.1016/0167-8396(89)90026-5

IF: 1.368

1989-06-01

Computer Aided Geometric Design

Abstract:
Reinvestigation of the metabolism of estriol-16 glucosiduronate in subjects with biliary T-tube drainage.

H. Jirku,S. Kadner,M. Levitz

DOI: https://doi.org/10.1210/JCEM-32-6-819

1971-06-01

Abstract:ABSTRACT The biliary and urinary metabolites of 3H-estriol-16 glucosiduronate (E3-16G) were studied in 4 subjects, each of whom had biliary T-tube drainage following cholecystectomy. The biliary excretion of tritium ranged from 3.7 to 27.5%, whereas the excretion in the urine was between 45.4 and 86.1%. The bile contained mostly estriol-3 sulfate-16 glucosiduronate (E3-3S-16G) and rather small amounts of E3-16G. The converse was true for the urine. No estriol-3 glucosiduronate (E3-3G) was identified in the urine, the maximum estimated amount being 0.5%. The detection of significant amounts of tritium in the bile is in disagreement with another report (Sandberg, A. A., and W. R. Slaunwhite, Jr., J Clin Invest 44: 694, 1965). When considered in conjunction with previous investigations, the results of this study strongly suggest that in intact subjects E3-3G is derived mainly, if not exclusively, from biliary E3-3S-16G and E3-16G.
Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples

Akshita Gupta,Anushika Soni,Sheetalnath Rooge,Diptanu Paul,Reshu Agarwal,Bansidhar Tarai,Ekta Gupta

DOI: https://doi.org/10.1016/j.jviromet.2021.114300

Abstract:The QIAstat-Dx SARS-CoV-2 panel is a multiplex cartridge based assay based on real time PCR which can detect 17 respiratory viruses, including the novel coronavirus SARS-CoV-2. A syndromic approach is the need of the hour for COVID-19 diagnostics among patients presenting with respiratory symptoms. The present study was done to evaluate 120 archived respiratory clinical specimens for SARS-CoV-2 on the SARS-CoV-2 panel. Further, 27 specimens were tested for other respiratory viruses, in comparison with the BioFire RP1.7 platform. The sensitivity and specificity for SARS-CoV-2 on SARS panel was found to be 90.00 % and 100 % respectively, indicating good diagnostic accuracy. The positive predictive value was found to be 100 %, negative predictive value was found to be 99.93 % and accuracy was 99.93 %. Detection of other respiratory viruses observed a concordance of 77.7 %. Despite advantages of speed, minimal expertise and accurate results; significant costs and discrepancies at Ct >35 remain important limitations of the SARS panel.
Detecting SARS-CoV-2 in the Breath of COVID-19 Patients

Xiaoguang Li,Jing Li,Qinggang Ge,Yuguang Du,Guoqiang Li,Wei Li,Tong Zhang,Lei Tan,Runqiang Zhang,Xiaoning Yuan,He Zhang,Chen Zhang,Wenjun Liu,Wei Ding,Liang Sun,Ke Chen,Zhuo Wang,Ning Shen,Jun Lu

DOI: https://doi.org/10.3389/fmed.2021.604392

IF: 3.9

2021-03-17

Frontiers in Medicine

Abstract:In the COVID-19 outbreak year 2020, a consensus was reached on the fact that SARS-CoV-2 spreads through aerosols. However, finding an efficient method to detect viruses in aerosols to monitor the risk of similar infections and enact effective control remains a great challenge. Our study aimed to build a swirling aerosol collection (SAC) device to collect viral particles in exhaled breath and subsequently detect SARS-CoV-2 using reverse transcription polymerase chain reaction (RT-PCR). Laboratory tests of the SAC device using aerosolized SARS-CoV-2 pseudovirus indicated that the SAC device can produce a positive result in only 10 s, with a collection distance to the source of 10 cm in a biosafety chamber, when the release rate of the pseudovirus source was 1,000,000 copies/h. Subsequent clinical trials of the device showed three positives and 14 negatives out of 27 patients in agreement with pharyngeal swabs, and 10 patients obtained opposite results, while no positive results were found in a healthy control group ( n = 12). Based on standard curve calibration, several thousand viruses per minute were observed in the tested exhalations. Furthermore, referring to the average tidal volume data of adults, it was estimated that an exhaled SARS-CoV-2 concentration of approximately one copy/mL is detectable for COVID-19 patients. This study validates the original concept of breath detection of SARS-CoV-2 using SAC combined with RT-PCR.

medicine, general & internal
Effect of ultrasound on sera of patients with articular disease and its investigation by means of immunoelectrophoresis and electrophoretic-polarographic analysis.

J. Stepan,J. Homolka,E. Paluska

DOI: https://doi.org/10.1159/000135589

Medicina et Pharmacologia Experimentalis

Abstract:

The survival of Listeria monocytogenes during long term desiccation is facilitated by sodium chloride and organic material.

Suppression of adrenocortical function in the rat by the prolonged administration of adrenal steroids. Proc. Soc. Endocr. 67th.

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.

Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.

Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR

Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Detection of hospital environmental contamination during SARS-CoV-2 Omicron predominance using a highly sensitive air sampling device

Non-isothermal extension of the Scharfetter-Gummel technique for hot carrier transport in heterostructure simulations

Evaluation of diagnostic performance of SARS-CoV-2 infection using digital droplet polymerase chain reaction in individuals with or without COVID-19 symptoms

A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples

Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications

Sampling and detection of corona viruses in air: A mini review

Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification

245 Detection of human respiratory pathogens in air and surface samples collected in several workplaces and public spaces

Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care

Efficient Microfluidic-Based Air Sampling/Monitoring Platform for Detection of Aerosol SARS-CoV-2 On-site

A set operation algorithm for sculptured solids modeled with trimmed patches

Reinvestigation of the metabolism of estriol-16 glucosiduronate in subjects with biliary T-tube drainage.

Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples

Detecting SARS-CoV-2 in the Breath of COVID-19 Patients

Effect of ultrasound on sera of patients with articular disease and its investigation by means of immunoelectrophoresis and electrophoretic-polarographic analysis.